Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/13/2009 First Published: 5/11/2006


1.		Phase III Randomized Study of Zoledronate in Preventing Osteoporosis and Associated Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiotherapy and Luteinizing Hormone-Releasing Hormone Agonist Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				NCI				RTOG-0518 0518, NCT00329797

Last Modified: 1/14/2009 First Published: 8/13/2006


2.		Phase III Randomized Study of Zoledronate, Vitamin D, and Calcium With or Without Strontium Chloride Sr 89 or Samarium Sm 153 Lexidronam Pentasodium in Preventing or Delaying Skeletal-Related Events in Patients With Bone Metastases Secondary to Prostate, Lung, or Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				NCI				RTOG-0517 RTOG 0517, NCT00365105


3.		A Study of Actonel for the Prevention of Bone Loss

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Other				ID03-0124 NCT00452439

Last Modified: 9/3/2008 First Published: 4/21/2006


4.		Phase II Randomized Study of Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				UMN-2005NT018 UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932

Last Modified: 10/30/2008 First Published: 12/21/2006


5.		Phase II Pilot Study of Vitamin D Deficiency and Myalgias and/or Arthralgias in Postmenopausal Women Receiving Adjuvant Letrozole for Stage I-III Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Natural history/Epidemiology, Supportive care, Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				UWCC-6346 6346, NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715

Select All on One Page